|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
2
|
Hannibal CG, Cortes R, Engholm G and Kjaer
SK: Survival of ovarian cancer patients in Denmark: Excess
mortality risk analysis of five-year relative survival in the
period 1978–2002. Acta Obstet Gynecol Scand. 87:1353–1360. 2008.
View Article : Google Scholar
|
|
3
|
Bast RC Jr, Hennessy B and Mills GB: The
biology of ovarian cancer: New opportunities for translation. Nat
Rev Cancer. 9:415–428. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Muggia F: Platinum compounds 30 years
after the introduction of cisplatin: Implications for the treatment
of ovarian cancer. Gynecol Oncol. 112:275–281. 2009. View Article : Google Scholar
|
|
5
|
Bartouskova M, Melichar B and
Mohelnikova-Duchonova B: Folate receptor: A potential target in
ovarian cancer. Pteridines. 26:1–12. 2015. View Article : Google Scholar
|
|
6
|
Kunická T, Václavíková R, Hlaváč V, Vrána
D, Pecha V, Rauš K, Trnková M, Kubáčková K, Ambruš M, Vodičková L,
et al: Non-coding polymorphisms in nucleotide binding domain 1 in
ABCC1 gene associate with transcript level and survival of patients
with breast cancer. PLoS One. 9:e1017402014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hlavata I, Mohelnikova-Duchonova B,
Vaclavikova R, Liska V, Pitule P, Novak P, Bruha J, Vycital O,
Holubec L, Treska V, et al: The role of ABC transporters in
progression and clinical outcome of colorectal cancer. Mutagenesis.
27:187–196. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mohelnikova-Duchonova B, Brynychova V,
Oliverius M, Honsova E, Kala Z, Muckova K and Soucek P: Differences
in transcript levels of ABC transporters between pancreatic
adenocarcinoma and nonneoplastic tissues. Pancreas. 42:707–716.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Eyre R, Harvey I, Stemke-Hale K, Lennard
TW, Tyson-Capper A and Meeson AP: Reversing paclitaxel resistance
in ovarian cancer cells via inhibition of the ABCB1 expressing side
population. Tumour Biol. 35:9879–9892. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Surowiak P, Materna V, Kaplenko I,
Spaczynski M, Dietel M, Lage H and Zabel M: Topoisomerase 1A,
HER/2neu and Ki67 expression in paired primary and relapse ovarian
cancer tissue samples. Histol Histopathol. 21:713–720.
2006.PubMed/NCBI
|
|
11
|
Bram EE, Stark M, Raz S and Assaraf YG:
Chemotherapeutic drug-induced ABCG2 promoter demethylation as a
novel mechanism of acquired multidrug resistance. Neoplasia.
11:1359–1370. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Auner V, Sehouli J, Oskay-Oezcelik G,
Horvat R, Speiser P and Zeillinger R: ABC transporter gene
expression in benign and malignant ovarian tissue. Gynecol Oncol.
117:198–201. 2010. View Article : Google Scholar
|
|
13
|
Ehrlichová M, Mohelnikova-Duchonova B,
Hrdy J, Brynychova V, Mrhalova M, Kodet R, Rob L, Pluta M, Gut I,
Soucek P, et al: The association of taxane resistance genes with
the clinical course of ovarian carcinoma. Genomics. 102:96–101.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lu L, Katsaros D, Wiley A, Rigault de la
Longrais IA, Puopolo M and Yu H: Expression of MDR1 in epithelial
ovarian cancer and its association with disease progression. Oncol
Res. 16:395–403. 2007.PubMed/NCBI
|
|
15
|
Bagnoli M, Beretta GL, Gatti L, Pilotti S,
Alberti P, Tarantino E, Barbareschi M, Canevari S, Mezzanzanica D
and Perego P: Clinicopathological impact of ABCC1/MRP1 and
ABCC4/MRP4 in epithelial ovarian carcinoma. Biomed Res Int.
2013:1432022013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hedditch EL, Gao B, Russell AJ, Lu Y,
Emmanuel C, Beesley J, Johnatty SE, Chen X, Harnett P, George J, et
al Australian Ovarian Cancer Study Group: ABCA transporter gene
expression and poor outcome in epithelial ovarian cancer. J Natl
Cancer Inst. 106:dju1492014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Januchowski R, Zawierucha P, Andrzejewska
M, Ruciński M and Zabel M: Microarray-based detection and
expression analysis of ABC and SLC transporters in drug-resistant
ovarian cancer cell lines. Biomed Pharmacother. 67:240–245. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Januchowski R, Zawierucha P, Ruciński M,
Andrzejewska M, Wojtowicz K, Nowicki M and Zabel M: Drug
transporter expression profiling in chemoresistant variants of the
A2780 ovarian cancer cell line. Biomed Pharmacother. 68:447–453.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Katano K, Safaei R, Samimi G, Holzer A,
Rochdi M and Howell SB: The copper export pump ATP7B modulates the
cellular pharmacology of carboplatin in ovarian carcinoma cells.
Mol Pharmacol. 64:466–473. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Samimi G, Safaei R, Katano K, Holzer AK,
Rochdi M, Tomioka M, Goodman M and Howell SB: Increased expression
of the copper efflux transporter ATP7A mediates resistance to
cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells.
Clin Cancer Res. 10:4661–4669. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Moreno-Smith M, Halder JB, Meltzer PS,
Gonda TA, Mangala LS, Rupaimoole R, Lu C, Nagaraja AS, Gharpure KM,
Kang Y, et al: ATP11B mediates platinum resistance in ovarian
cancer. J Clin Invest. 123:2119–2130. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hubackova M, Vaclavikova R, Ehrlichova M,
Mrhalova M, Kodet R, Kubackova K, Vrána D, Gut I and Soucek P:
Association of superoxide dismutases and NAD(P)H quinone
oxidoreductases with prognosis of patients with breast carcinomas.
Int J Cancer. 130:338–348. 2012. View Article : Google Scholar
|
|
23
|
Soucek P, Anzenbacher P, Skoumalová I and
Dvorák M: Expression of cytochrome P450 genes in CD34+
hematopoietic stem and progenitor cells. Stem Cells. 23:1417–1422.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mohelnikova-Duchonova B, Oliverius M,
Honsova E and Soucek P: Evaluation of reference genes and
normalization strategy for quantitative real-time PCR in human
pancreatic carcinoma. Dis Markers. 32:203–210. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bustin SA, Benes V, Garson JA, Hellemans
J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL,
et al: The MIQE guidelines: Minimum information for publication of
quantitative real-time PCR experiments. Clin Chem. 55:611–622.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hlaváč V, Brynychová V, Václavíková R,
Ehrlichová M, Vrána D, Pecha V, Koževnikovová R, Trnková M, Gatěk
J, Kopperová D, et al: The expression profile of ATP-binding
cassette transporter genes in breast carcinoma. Pharmacogenomics.
14:515–529. 2013. View Article : Google Scholar
|
|
27
|
Burger H, Zoumaro-Djayoon A, Boersma AW,
Helleman J, Berns EM, Mathijssen RH, Loos WJ and Wiemer EA:
Differential transport of platinum compounds by the human organic
cation transporter hOCT2 (hSLC22A2). Br J Pharmacol. 159:898–908.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kamal CK, Simionescu CE, Mărgăritescu C
and Stepan A: P53 and Ki67 immunoexpression in mucinous malignant
ovarian tumors. Rom J Morphol Embryol. 53(Suppl 3): S799–S803.
2012.
|
|
29
|
Kaminski WE, Orsó E, Diederich W, Klucken
J, Drobnik W and Schmitz G: Identification of a novel human
sterol-sensitive ATP-binding cassette transporter (ABCA7). Biochem
Biophys Res Commun. 273:532–538. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jessup W, Gelissen IC, Gaus K and
Kritharides L: Roles of ATP binding cassette transporters A1 and
G1, scavenger receptor BI and membrane lipid domains in cholesterol
export from macrophages. Curr Opin Lipidol. 17:247–257. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Beaufort CM, Helmijr JC, Piskorz AM,
Hoogstraat M, Ruigrok-Ritstier K, Besselink N, Murtaza M, van
IJcken WF, Heine AA, Smid M, et al: Ovarian cancer cell line panel
(OCCP): Clinical importance of in vitro morphological subtypes.
PLoS One. 9:e1039882014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kool M, van der Linden M, de Haas M,
Scheffer GL, de Vree JM, Smith AJ, Jansen G, Peters GJ, Ponne N,
Scheper RJ, et al: MRP3, an organic anion transporter able to
transport anti-cancer drugs. Proc Natl Acad Sci USA. 96:6914–6919.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhao Y, Lu H, Yan A, Yang Y, Meng Q, Sun
L, Pang H, Li C, Dong X and Cai L: ABCC3 as a marker for multidrug
resistance in non-small cell lung cancer. Sci Rep. 3:31202013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu J, Yong M, Li J, Dong X, Yu T, Fu X and
Hu L: High level of CFTR expression is associated with tumor
aggression and knockdown of CFTR suppresses proliferation of
ovarian cancer in vitro and in vivo. Oncol Rep. 33:2227–2234.
2015.PubMed/NCBI
|
|
35
|
Yasui K, Mihara S, Zhao C, Okamoto H,
Saito-Ohara F, Tomida A, Funato T, Yokomizo A, Naito S, Imoto I, et
al: Alteration in copy numbers of genes as a mechanism for acquired
drug resistance. Cancer Res. 64:1403–1410. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
He QZ, Luo XZ, Wang K, Zhou Q, Ao H, Yang
Y, Li SX, Li Y, Zhu HT and Duan T: Isolation and characterization
of cancer stem cells from high-grade serous ovarian carcinomas.
Cell Physiol Biochem. 33:173–184. 2014. View Article : Google Scholar : PubMed/NCBI
|
